Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 3Lymphoid 2Genitourinary 2Gastrointestinal 2Sarcoma 1Other hematologic neoplasm 1Dermatologic 1

Conditions

Carcinoma, Hepatocellular 2

Interventions

Oxaliplatin 288Capecitabine 218Fluorouracil 212Irinotecan 145Leucovorin 139Gemcitabine 124S 1 (combination) 110apatinib 109Cisplatin 102Drug Therapy 98Bevacizumab 98Radiotherapy 97Paclitaxel 97camrelizumab 89sintilimab 79Cetuximab 75lenvatinib 62Neoadjuvant Therapy 61tislelizumab 55Surgical Procedures, Operative 54Sorafenib 53Folfox protocol 53toripalimab 52Docetaxel 52130-nm albumin-bound paclitaxel 47Laparoscopy 41HMPL-013 40XELOX 39Radiosurgery 36Albumin-Bound Paclitaxel 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × pirarubicin × Gastrointestinal × Clear all
NCT02755311 2016-04-28

Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma

Sun Yat-sen University

Phase 3 Unknown
198 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02301091 2016-04-14

CORTT

Sun Yat-sen University

Phase 3 Unknown
240 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡